Armephaco JSC

Armephaco JSC Operating Expenses

The Total Operating Expenses of Armephaco JSC (AMP.VN) as of Oct 19, 2026 is 66.75 B VND. In the previous year, Total Operating Expenses was 73.78 B VND — a change of -9.53% (lower).

Operating Expenses

66.75 BVND

YoY

-9.53%

Last updated:

Total Operating Expenses of Armephaco JSC is 2025 66.75 B VND. Total Operating Expenses of Armephaco JSC was 2024 73.78 B VND. It decreases by -9.53% lower compared to the previous year.

The Armephaco JSC Operating Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Expenses
Date
Operating Expenses
Jan 1, 2018
70.55 B VND
Jan 1, 2019
63.42 B VND
Jan 1, 2020
60.47 B VND
Jan 1, 2021
62.56 B VND
Jan 1, 2022
58.53 B VND
Jan 1, 2023
59.93 B VND
Jan 1, 2024
73.78 B VND
Jan 1, 2025
66.75 B VND
The Armephaco JSC Operating Expenses history
YEAROperating ExpensesYoY
66.75 BVND-9.53%
73.78 BVND+23.10%
59.93 BVND+2.41%
58.53 BVND-6.44%
62.56 BVND+3.45%
60.47 BVND-4.65%
63.42 BVND-10.10%
70.55 BVND+4.77%
67.34 BVND-1.19%
68.15 BVND-3.71%
70.78 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

Total Operating Expenses of Armephaco JSC is 66.75 B VND in 2025.

Total Operating Expenses of Armephaco JSC changed from 73.78 B VND to 66.75 B VND, representing a -9.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's Armephaco JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Armephaco JSC

All Key Metrics — Armephaco JSC